Article

The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease

2021-02-01

Abstract excerpt

Currently, SARS-CoV-2 infection which is the causative agent for COVID-19 disease is a worldwide pandemic with more than 100 million global cases and more than 2.0 million deaths (as of January, 2021). While several vaccines for prevention of COVID-19 have already been registered by the regulatory authorities, the problem is that the substitution rate of this virus is estimated to be one change per 2 weeks, thus m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa94f4d8-f226-5dce-8088-9e638ebe808f
DOI: 10.20944/preprints202002.0147.v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 diseaseDOI 10.20944/preprints202002.0147.v4Read

Sting Pathway Activation by Orally Administered Attenuated dsRNA Vaccine Virus for Therapy of Viral DiseasesSemantic proximity Read

A Harmless Avian Vaccine Virus Could Be Developed into an Off-the-Shelf “Antibiotic” for VirusesSemantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19Semantic proximity Read

Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionSemantic proximity Read

An Overview on Drug Evolution and Trials on Pandemic COVID-19 InfectionSemantic proximity Read

Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development ArenaSemantic proximity Read

REGEN-COV Antibody Combination in Outpatients With COVID-19 – Phase 1/2 ResultsSemantic proximity Read

REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 OutpatientsSemantic proximity Read

Facing the challenge of viral mutations in the age of pandemic: Developing highly potent, broad-spectrum, and safe COVID-19 vaccines and therapeutics.Semantic proximity Read

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals.Semantic proximity Read

Vaccination is the most effective and best way to avoid the disease of COVID‐19Semantic proximity Read